Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: reg who wrote (2160)	3/26/1999 6:46:00 PM
From: AJAG	of 10280

Cheer up Sepracor fans! If you do your research, you will see that it is not unusual for a sell-off upon FDA approval. The theory- now the company must actually execute the sales rollout, etc. However, we are not talking about a one-drug company here. We already have Allegra on the market, and now we have a potential blockbuster, ie, an improved version (safer and more powerful at lower dose) of what is presently a billion plus per year drug (sold as a generic). We got the label reference to safety. And we could get more news anytime on new deals with the big pharmaceuticals companies. OIur pipeline includes improved versions of Claritin, Prozac, Hismanal, and Propulsid. Our partners are Johnson and Johnson, Lilly, Schering Plough and additional players to be named later. Our market cap is a little over 3 billion dollars (compared to Amgen at 34 billion).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next